| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 46.8962 | 36 |
| GSM780708 | Untreated after 4 days (C2_1) | 48.2672 | 42 |
| GSM780709 | Untreated after 4 days (C3_1) | 49.079 | 45 |
| GSM780719 | Untreated after 4 days (C1_2) | 50.0764 | 49 |
| GSM780720 | Untreated after 4 days (C2_2) | 44.7026 | 26 |
| GSM780721 | Untreated after 4 days (C3_2) | 47.5514 | 39 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 49.2886 | 46 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 45.9774 | 32 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 43.9995 | 22 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 48.2911 | 42 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 50.7399 | 51 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 51.2883 | 52 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 47.7327 | 40 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 53.0398 | 56 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 49.1454 | 46 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 54.1868 | 58 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 49.1394 | 46 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 45.5835 | 30 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 48.4115 | 43 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 56.3215 | 61 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 48.4239 | 43 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 52.334 | 55 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 50.5343 | 50 |